MALDI-TOF MSIA Ligand Binding Assay Throughput
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ligand binding assays, such as ELISA, are limited by being time-consuming, less sensitive, and costly, necessitating a more efficient and cost-effective alternative for characterizing molecular interactions and detecting target molecules.
Innovation Solution
A highly multiplexed Mass Spectrometric ImmunoAssay (MSIA) using MALDI-TOF mass spectrometry with biotinylated Streptavidin Sepharose beads and a label-free approach for ligand binding assays, enabling faster, more sensitive, and cost-effective detection and characterization of molecular interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If ELISA is used for ligand binding assays, then the assay can detect target molecules, but the process is time-consuming and low-throughput
Solution Approach 1:
The patent replaces the enzymatic detection system (mechanical/chemical amplification through enzyme-substrate reactions in ELISA) with mass spectrometric detection. The MALDI-TOF MS directly measures the mass-to-charge ratio of ligand-receptor complexes, eliminating the need for multiple enzymatic steps, substrate additions, and signal amplification procedures, thereby dramatically reducing assay time and increasing throughput.
Solution Approach 2:
The patent extracts and removes the time-consuming enzymatic detection steps from the assay protocol. By using direct mass spectrometric detection, the method eliminates the need for enzyme incubation, substrate conversion, and colorimetric/fluorometric readout steps that characterize traditional ELISA, achieving rapid high-throughput screening.
2Measurement precision
If traditional detection methods are used, then the assay can measure ligand-receptor interactions, but the sensitivity is insufficient
Solution Approach 1:
The patent changes the detection parameter from optical signal intensity (in ELISA) to mass-to-charge ratio measurement. Mass spectrometry provides inherent mass resolution and accuracy, allowing direct measurement of molecular masses with high precision. This parameter change enables detection of low-abundance ligand-receptor complexes with superior sensitivity and quantitative accuracy.
Solution Approach 2:
The substitution of enzymatic amplification with direct mass spectrometric detection eliminates the limitations of optical detection sensitivity. The mass spectrometer directly detects and quantifies ligand-receptor complexes based on their unique mass signatures, providing superior sensitivity without requiring signal amplification steps that can compromise accuracy.
3Ease of manufacture
If ELISA is used for molecular interaction characterization, then the assay can provide binding data, but the cost is high
Solution Approach 1:
The patent employs a universal mass spectrometric detection platform that can analyze multiple ligand-receptor interactions simultaneously through multiplexed analysis. The MALDI-TOF MS can detect various molecular complexes in a single run by measuring their distinct mass-to-charge ratios, enabling high-throughput screening of multiple targets without requiring separate assays for each interaction, thereby reducing per-sample cost while increasing productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The MSIA method provides rapid, high-throughput, and highly sensitive detection of molecular interactions with a lower cost, capable of screening for autoimmune and tumor antigens, drug discovery, and developing drug compounds with minimal side effects.
Implementation Method 1
A highly multiplexed Mass Spectrometric ImmunoAssay (MSIA) using MALDI-TOF mass spectrometry
Implementation Method 2
biotinylated Streptavidin Sepharose beads
Data Source
AI summary
An apparatus for ligand binding assays includes an incubator that incubates a plurality of beads with a sample of interest wherein each of the plurality of beads comprises a tag of predetermined mass and a bait molecule. A washer washes the incubated beads so that weakly bound molecules are removed while strongly bound molecules are retained. A sample plate loader loads the washed beads into the sample plate such that respective ones of the plurality of beads are loaded into respective ones of the plurality of well. A sprayer deposits matrix assisted laser desorption ionization (MALDI) matrix material on the surface of the sample plate so that each of the plurality of beads is exposed to MALDI matrix material. A MALDI-TOF mass spectrometer receives the sample plate and performs mass spectrometry on samples in the plurality of wells. A computer executes an algorithm that analyzes the mass spectra.